These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8009056)

  • 21. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
    Zheng X; Abroun S; Otsuyama K; Asaoku H; Kawano MM
    Haematologica; 2006 Jul; 91(7):920-8. PubMed ID: 16818279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthesis of immunoglobulin in human immunoproliferative diseases. II. Comparison of tumour cell mass in multiple myeloma measured by synthetic rate studies with that calculated from clinical staging systems.
    Cooper DA; Miller AC; Penny R
    Acta Haematol; 1982; 68(3):224-36. PubMed ID: 6814151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anion gap among patients of multiple myeloma and normal individuals.
    Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
    Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition of RPMI 8226 human myeloma cells by peripheral blood lymphocytes.
    Amano T; Katagiri S; Tominaga N; Oritani K; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
    Acta Haematol; 1992; 87(1-2):37-44. PubMed ID: 1350158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significant increase of FcγRIIIA (CD16), a sensitive marker, in patients with coronary heart disease.
    Huang Y; Yin H; Wang J; Ma X; Zhang Y; Chen K
    Gene; 2012 Aug; 504(2):284-7. PubMed ID: 22613847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
    Kasamatsu T; Ozaki S; Saitoh T; Konishi J; Sunami K; Itagaki M; Asaoku H; Cho T; Handa H; Hagiwara S; Wakayama T; Negoro A; Takezako N; Harada N; Kuroda Y; Nakaseko C; Miyake T; Inoue N; Hata H; Shimazaki C; Ohno T; Kuroda J; Murayama T; Kobayashi T; Abe M; Ishida T; Nagura E; Shimizu K
    Hematol Oncol; 2018 Dec; 36(5):792-800. PubMed ID: 30176173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical Value of Serum Fructosamine Measurement in IgA Type Multiple Myeloma].
    Zhang JY; Fan H; Chen LX; Wang LF; Wang HF; Shi HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):494-497. PubMed ID: 28446300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.
    Petitprez V; Royer B; Desoutter J; Guiheneuf E; Rigolle A; Marolleau JP; Kamel S; Guillaume N
    Int J Lab Hematol; 2015 Feb; 37(1):29-35. PubMed ID: 24661393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors.
    Khayat D; Soubrane C; Andrieu JM; Visonneau S; Eme D; Tourani JM; Beldjord K; Weil M; Fernandez E; Jacquillat C
    J Infect Dis; 1990 Mar; 161(3):430-5. PubMed ID: 2138203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load.
    Bergenbrant S; Osterborg A; Holm G; Mellstedt H; Lefvert AK
    Br J Haematol; 1991 May; 78(1):66-70. PubMed ID: 2043484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
    Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
    Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
    J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell frequency and function in patients with monoclonal gammopathies.
    Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
    J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal Immunization with Cry1Ac Protoxin from Bacillus thuringiensis Provokes Upregulation of Fc-Gamma-II/and Fc-Gamma-III Receptors Associated with IgG in the Intestinal Epithelium of Mice.
    Moreno-Fierros L; Verdín-Terán SL; García-Hernández AL
    Scand J Immunol; 2015 Jul; 82(1):35-47. PubMed ID: 25904149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual plasma cell analysis.
    Pojero F; Casuccio A; Parrino MF; Cardinale G; Colonna Romano G; Caruso C; Gervasi F
    Cytometry B Clin Cytom; 2015; 88(3):165-82. PubMed ID: 25529228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.